Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Saltsjöbaden – page 53

771 clinical trials in Saltsjöbaden, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Saltsjöbaden at a glance
771
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

771 trials in Saltsjöbaden

Open in trial search

Cardiac amyloidosis

Not recruiting

Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:ALXN2220
  • Sponsor:Alexion Pharmaceuticals Inc.

Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Association International Extranodal Lymphoma Study Group (IELSG)

Dermatitis atopic

Not recruiting

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study Comparing Human Normal Immunoglobulin and Placebo for Children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Octapharma Pharmazeutika Produktionsgesellschaft mbH

Study on Latent Autoimmune Diabetes in Adults (LADA) Patients: Evaluating Diabetes Status 3 Years After Treatment with Glutamate Decarboxylase 2

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Retogatein
  • Sponsor:Norwegian University Of Science And Technolology

Cardiac failure chronic+1

Not recruiting

Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Bayer AG

Ovarian cancer

Not recruiting

Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Niraparib Tosilate Monohydrate
  • Sponsor:Tesaro Inc.

Study Comparing Asciminib with Other Drug Combinations for Adults with Newly Diagnosed Chronic Myeloid Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:Novartis Pharma AG

Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:65+ years
  • Substances:Dexamethasone
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:AP-101
  • Sponsor:AL-S Pharma AG

Anal cancer recurrent

Not recruiting

Study of Retifanlimab, Carboplatin, and Paclitaxel for Patients with Inoperable or Metastatic Anal Canal Squamous Cell Carcinoma Not Treated with Chemotherapy

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Incyte Corp.

Breast cancer

Not recruiting

Study of Trastuzumab Deruxtecan with or without Pertuzumab for Patients with HER2-positive Metastatic Breast Cancer

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AstraZeneca AB

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Saltsjöbaden

What the registry says about research in the country

01 Diseases [C] - Virus Diseases [C02]

In Saltsjöbaden, clinical research in this area focuses on RSV infection and the immune response to prevention-focused interventions. These studies are looking at how well a new approach can support protection against respiratory viral illness in older adults.

  • RSV infection
  • Respiratory tract diseases
  • Evaluating immune protection against viral infection

The work is centered on understanding whether the intervention can strengthen the body’s defense against RSV and help reduce the impact of this common respiratory virus.

02 Diseases [C] - Respiratory Tract Diseases [C08]

This research field covers trials aimed at preventing or reducing illness related to respiratory tract diseases, with a strong focus on RSV infection. The main goal is to assess how effective a vaccine-based strategy may be in older adults.

  • Respiratory tract disease prevention
  • RSV antibody response
  • Testing a new preventive therapy

These studies help clarify whether the intervention can improve protection in populations more vulnerable to severe respiratory infections.

03 Diseases [C] - Bacterial Infections and Mycoses [C01]

Clinical trials in this therapeutic area are examining treatment options for Diabetic Foot Ulcer, a wound complication where infection control and healing are major concerns. The research is focused on finding better local antimicrobial care to support complete wound closure.

  • Diabetic Foot Ulcer
  • Bacterial infection management
  • Improving wound healing outcomes

In Sweden, this line of research is comparing approaches that may help clinicians choose more effective treatments for difficult-to-heal ulcers.

04 Diabetic Foot Ulcer

The trial activity around Diabetic Foot Ulcer is aimed at evaluating how well local antimicrobial agents help wounds heal. It is a practical, patient-centered area of research focused on treatment effectiveness and recovery.

  • Local antimicrobial treatment
  • Time to healing
  • Wound care and infection control

These studies are intended to improve everyday care for people living with chronic foot ulcers linked to diabetes.

05 RSV infection

Research on RSV infection is centered on prevention and immune response in older adults, especially those at higher risk of severe disease. The trials are assessing whether a new protective strategy can generate helpful neutralizing antibodies.

  • Older adult respiratory health
  • Immune response to RSV
  • Preventive vaccine research

This work supports better understanding of how to reduce the burden of RSV in aging populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.